Conditions: Perennial Allergic Rhinitis
Allocation: NON_RANDOMIZED | Intervention model: PARALLEL
Enrollment: 261
Healthy volunteers: no

Brief summary:
This is a post marketing study to confirm the appropriate dose of loratadine in children by obtaining drug concentration data at multiple time points per child and adult patient, after the patient receives repeated administrations of the approved dose of loratadine.

Detailed description:

Arms:
arm 1: Pediatrics 3 to 6 years arm 2: Pediatrics 7 to 15 years arm 3: Adults 16 to 64 years

Interventions: intervention 1: loratadine intervention 2: loratadine intervention 3: loratadine
Intervention descriptions: intervention 1: Loratadine (SCH 29851) dry syrup 1% 5 mg/day for 4 weeks intervention 2: loratadine 10 mg tablet once daily for 4 weeks intervention 3: loratadine 10 mg tablet once daily for 4 weeks

Protocol document: